Indivior Pharmaceuticals Inc. Common Stock vs INNIO N.V. Ordinary Shares — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.01 (market cap $4.18B), while INNIO N.V. Ordinary Shares trades at $16.22 (market cap $13.73B). The key difference: INNIO N.V. Ordinary Shares is far larger — about 3.3× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Indivior Pharmaceuticals Inc. Common Stock is trading nearer its 52-week high, INNIO N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and INNIO N.V. Ordinary Shares for 0 Days on average.
| INDV | INIO | |
|---|---|---|
Market Cap | $4.18B | $13.73B |
Volume | 1,819,746 | 5,012,195 |
Sector | Health | Industrials |
52-Week High | $41.83 | $41.13 |
52-Week Low | $24.09 | $16.50 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.47B | $15.39B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →INNIO Group designs, manufactures, and services reciprocating gas engines for distributed power generation under its Jenbacher and Waukesha brands, serving applications from data centers to industrial and grid-stabilization uses.
Read more on INIO →